ストックスクリーナーアプリを入手
1.47
2.80%
0.04
前日終値:
$1.43
開ける：
$1.46
24時間の取引高:
66,974
Relative Volume:
0.81
時価総額：
$74.65M
収益：
$697.00K
当期純損益:
$-39.78M
株価収益率:
-0.8802
EPS:
-1.67
ネットキャッシュフロー:
$-8.90M
1週間 パフォーマンス:
+5.76%
1か月 パフォーマンス:
-4.55%
6か月 パフォーマンス:
-18.78%
1年 パフォーマンス:
-3.92%
1日の値動き範囲:
$1.42
$1.47
1週間の範囲:
$1.28
$1.47
52週間の値動き範囲:
$1.28
$2.50
Rafael Holdings Inc Stock (RFL) Company Profile
RFL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RFL
Rafael Holdings Inc
|
1.47 | 48.42M | 697.00K | -39.78M | -8.90M | -1.67 |
|
BEKE
Ke Holdings Inc Adr
|
18.00 | 21.95B | 12.30B | 566.18M | 1.32B | 0.4805 |
|
CBRE
Cbre Group Inc
|
124.56 | 36.94B | 36.74B | 1.01B | 1.35B | 3.27 |
|
CSGP
Costar Group Inc
|
73.27 | 31.48B | 2.81B | 117.20M | -30.60M | 0.29 |
|
IRS
Irsa Inversiones Y Representaciones S A Adr
|
15.15 | 1.16B | 475.71M | 502.84M | 88.69M | 7.1981 |
|
JLL
Jones Lang Lasalle Inc
|
221.06 | 10.56B | 24.05B | 536.00M | 508.40M | 11.06 |
Rafael Holdings Inc (RFL) 最新ニュース
Rafael (NYSE:RFL) Trading Up 2.6% – Still a Buy? - Defense World
Protara Therapeutics names new Chief Commercial Officer By Investing.com - Investing.com India
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer - GlobeNewswire
Cancer Drug Veteran Behind Trodelvy Launch Joins Protara as Commercial Chief to Lead Market Strategy - Stock Titan
RFL stock touches 52-week low at $1.28 amid market challenges - Investing.com Australia
Rafael Holdings, Inc. Provides Update to the Description of Subscription Rights Related to its Public Warrants in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trap - The Manila Times
Oruka Therapeutics Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody - The Manila Times
Rafael Holdings Rights Offering: $25M Deal Terms Revealed, May 29 Deadline Approaches - Stock Titan
Ekso Bionics reports Q1 results, plans reverse stock split - The North Bay Business Journal
Ekso Bionics Accepted into NVIDIA Connect Program - Quantisnow
Rafael : to Present at LD Micro Investor Conference - marketscreener.com
Rafael Holdings Enters Standby Purchase Agreement with Chairman - TipRanks
SEC Form 424B3 filed by Rafael Holdings Inc. - Quantisnow
Ekso Bionics: Q1 Earnings Snapshot - CTPost
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - ADVFN
Rafael announces revised subscription rights in connection with offering - TipRanks
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously Announced $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Rafael Holdings, Inc. Announces Revised Subscription Rights in Connection With its Previously ... - Bluefield Daily Telegraph
Rafael Holdings Launches $25M Rights Offering: Key Dates and Terms Investors Must Know - Stock Titan
Ichnos Glenmark Innovation (IGI) Receives U.S. FDA Fast Track Designation for ISB 2001 for Relapsed/Refractory Multiple Myeloma - The Manila Times
Oculis Holding AG (NASDAQ:OCS) Shares Bought by Geode Capital Management LLC - Defense World
Taseko Mines Limited (NYSE:TGB) Shares Purchased by Geode Capital Management LLC - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
LD Micro 360 Companies: --Set to Present this Week. - ACCESS Newswire
Metric Deep Dive: Understanding Rafael Holdings Inc (RFL) Through its Ratios - DWinneX
Tronox Holdings plc: Navigating Market Fluctuations with a 857.28M Market Cap - investchronicle.com
Rafael Holdings Inc (RFL) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™ - The Manila Times
Sonoco Reports First Quarter 2025 Results - The Manila Times
Rafael Holdings Secures Future: $25M Rights Offering Powers Critical Phase 3 Drug Launch Plans - Stock Titan
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo - The Globe and Mail
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - The Manila Times
Rafael Holdings Strengthens its Focus on the Development of Trappsol Cyclo and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role - marketscreener.com
Rafael Holdings CEO Resignation Announced - TipRanks
WillScot Announces Investor Conference Schedule for May 2025 - The Manila Times
Rafael Holdings Announces Leadership Transition Following Merger with Cyclo Therapeutics and Full Enrollment of TransportNPC™ Phase 3 Trial for Niemann-Pick Disease Treatment - Nasdaq
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces ... - Bluefield Daily Telegraph
Rafael Holdings Pivots to Breakthrough Rare Disease Drug Development as Leadership Changes - Stock Titan
Form 8-KCurrent report - ADVFN
SEC Form S-3 filed by Ekso Bionics Holdings Inc. - Quantisnow
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, VGR, TTNP on Behalf of Shareholders - ACCESS Newswire
General Atomics Partners With Rafael to Build Precision-Guided Missile for U.S. Defense Customers - Yahoo Finance
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GVP, AFBI, RFL, MNTX on Behalf of Shareholders - ACCESS Newswire
Autodesk announces Betsy Rafael to step down from Board of Directors - Yahoo Finance
Rafael Holdings finalizes merger with Cyclo Therapeutics By Investing.com - Investing.com South Africa
Rafael Closes Merger With Cyclo Therapeutics - MarketScreener
Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals - MarketScreener
Cyclo Therapeutics Merges with Rafael Holdings - TipRanks
Does Rafael Holdings (NYSE:RFL) Have A Healthy Balance Sheet? - simplywall.st
Rafael Holdings Completes Merger with Cyclo Therapeutics - TipRanks
Volatility Alert: 10 Stocks Showing High IV Percentile - The Globe and Mail
Rafael Holdings Inc (RFL) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
1.00%
大文字化:
|
ボリューム (24 時間):